Investing Profile

Jonathan Leff

InvestorVC
Partner at Deerfield Management
Photo of Jonathan Leff, Partner at Deerfield Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$10.0M - $50.0M
$25.0M
8
CompanyStageDateRound SizeTotal Raised
BIOMx
Post Ipo EquityMar 2024$50M
$50M
Adaptive Phage Therapeutics
Series BMay 2021$41M
$61M
Co-investors: Martin Heidecker (AMR Action Fund)
Mirum Pharmaceuticals
Series ANov 2018$120M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Patrick Heron (Frazier Healthcare Partners), Niall O’Donnell (RiverVest)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Co-investors: Carole Nuechterlein (Roche Venture Fund)
Audentes Therapeutics
Series BDec 2014$43M
$140M
Co-investors: Jonathan Silverstein (OrbiMed), Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Tom Woiwode (Versant Ventures)
Hana Biosciences
Private EquityJun 2010$100M
$100M
Altus Pharmaceuticals
Series CMay 2004$51M
$100M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))